NEW YORK, July 30 – Gene Logic of Gaithersburg, Md., said Monday its second quarter revenue surged 41 percent to $9.6 million, compared with $6.8 million in the year ago period, as the company sold several new subscriptions to its GeneExpress databases.

The company now has 18 pharmaceutical and biotechnology customers for its various database modules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.